资源描述：
《幽门螺杆菌对抗生素耐药性的研究进展》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、·558·医学综述2007年4月第13卷第7期 MedicalRecapitulate,April2007,Vol.13,No.7参考文献:[10]PebleyW,JagerN,ThompsonJ.Rapidlydisintegratingtablet[P].The[1]审评四部,口崩片的剂型特点和质量控制会议纪要[EBPOL].UnitedStatesPatent:5298261,1994205229.http:PPwww.cde.org.cnP2003208202[11]GoleD,WilkinsonP,DaviesJ.Pharmaceu
2、ticalandotherdosageform.[2]DowsonA,MacGregorE,PurdyR,etal.Zolmitriptanorallydisinte2[P].TheUnitedStatesPatent:WO9323017(A61K9P20,9P00).19932gratingtabletiseffectiveintheacutetreatmentofmigraine[J].Cepha211225.lalgia,2002,22(2):1012106.[12]AllenL,DaviesJ.Rapidlydissolvingora
3、ldosageform.[P].WordIn2[3]LoderE,BrandesJ,SibersteinS,etal.PreferencecomparisonoftellectualPropertyOrgnization:WO9520377(A61K9P00,9P20),19952rizatriptanODT10mgandsumatriptan50mgtabletinmigraine[J].08203.Headache,2001,41(8):745.[13]ItoA,SugiharaM.Developmentoforaldosageformf
4、orelderlypatients:[4]KinonB,HillA,LiuH,etal.Olanzapineorallydisintegratingtabletsuseofagarasbaseofrapidlydisintegratingoraltablets[J].Cheminthetreatmentofacutelyillnon2compliantpatientswithschizophreniaPharmBull,1996,44(11):213222136.[J].IntJNeuropsychopharmacol,2003,6(2):9
5、72102.[14]KatoY,MatsumotoK,OhkumaM,etal.Rapidlydisintegratingtablets[5]IshikawaT,KoizumiN,MukaiB,etal.Pharmacokineticsofacetamino2preparedbyasurface2modifyingmethodcomparisonofdisintegrantsphenfromrapidlydisintegratingcompressedtabletpreparedusingmi2[J].PharmSciTechnolJpn,2
6、002,62(3):87.crocrystallinecellulose(PH2M206)andsphericalsugargranules[J].[15]SuzukiE,ZhuNL,HilonakaK.RapidlydisintegratingtabletinoralChemPharmBull(Tokyo),2001,49(2):2302232.cavityandmethodforproducingthesame[P].JapanesePatent:[6]MarkowitzJ,DevaneL,MalcolmR,etal.Pharmacoki
7、neticsofolanzap2255796,2002209211.ineaftersingle2doseoraladministrationofstandardtabletversusnormal[16] 李晓芳,金描真,欧少英,等.对乙酰氨基酚口崩片的研制[J].andsublingualadministrationofanorallydisintegratingtabletinnormal中国现代应用药学,2005,22(5):3952398.volunteers[J].JClinPharmacol,2006,46(2):1642171
8、.[17]CherukunS,MyersL.Processforformingquicklydispersringcommeti2[7]SwanS,AlcornH,
